'Fdg pet' diaporamas de présentation

1.68k views • 101 slides

The Role of PET/CT in Differentiated Thyroid Cancer Managment

The Role of PET/CT in Differentiated Thyroid Cancer Managment. Presented By:B.Rezvankhah MD Research Institute for Endocrine Sciences Shahid Beheshti University of Medical Sciences June 2017. Agenda. Case presentation Introduction(Principles of PET/CT)

1.33k views • 87 slides

KHALED AJARMA MD FACS 17 TH NOV . 2012

KHALED AJARMA MD FACS 17 TH NOV . 2012. EMBRYOLOGY. Greek (shield-shaped)

937 views • 75 slides

Tumor Imaging

Tumor Imaging. We have a lot of selections for Tumor Imaging. Tumor is more metabolic active. 18F-FDG, 18F-FLT, 11C-acetate, 11C-cholin, 201Tl, 99mTc-MIBI. Tumor has specific receptors. 131I-MIBG, 131I-anti-AFP-MoAb Tumor can cause function and structure changes. BBB destruction, 99mTc-PMT

790 views • 47 slides

Emily Stern, MD Director, Functional Neuroimaging Laboratory

Imaging In Traumatic Brain Injury: What Have We Learned? A Functional and Molecular Neuroimaging Perspective. Emily Stern, MD Director, Functional Neuroimaging Laboratory Director, Functional and Molecular Neuroimaging Departments of Radiology and Psychiatry Associate Professor of Radiology.

547 views • 45 slides

498 views • 42 slides

Stage I Lung Radiosurgery: Overview, Results, and Current RTOG Studies

Stage I Lung Radiosurgery: Overview, Results, and Current RTOG Studies. Douglas Johnson, MD, FACR Florida Radiation Oncology Group ACRIN Sept 2010 Annual Meeting. Stereotactic Body Radiotherapy. High ablative dose SRS= single Fx SBRT= 2-5 Fx

916 views • 41 slides

Positron Emission Tomography (PET) Jann Mortensen

Positron Emission Tomography (PET) Jann Mortensen Department of Nuclear Medicine & PET, Rigshospitalet, Copenhagen, Denmark. E-mail: jannmortensen@rh.dk. 8th Annual Congress, Thoracic imaging in lung diseases, April 30th 2005. annihilation photon. g. electron/positron annihilation. b -.

716 views • 41 slides

792 views • 36 slides

GASTROINTESTINAL STROMAL TUMORS (GIST) IN NEUROFIBROMATOSIS 1 (NF1) PATIENTS: A CLINICOPATHOLOGIC ANALYSIS OF NINE CAS

636 views • 26 slides

PET in der Diagnostik des Bronchuskarzinoms

494 views • 23 slides

Obscured Bone Metastases After Administration of Hematopoietic Factor on FDG-PET

342 views • 22 slides

376 views • 19 slides

Dementia

UNIVERSITY OF. CAMBRIDGE. Dementia. Dr Peter J Nestor peter.nestor@mrc-cbu.cam.ac.uk. Imaging challenging patients.

290 views • 17 slides

April 28, 2012 ???? ????? ?????

260 views • 16 slides

Generation of multiple respiratory phases in PET/CT A phantom study

266 views • 14 slides

9/30/10

ACRIN 6682 Phase II Trial of 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD. 9/30/10. Background. Tumor hypoxia is an important prognostic factor in cervical cancer and predicts for decreased overall and disease-free survival

206 views • 13 slides

10/2/09

ACRIN 6682 Phase II Trial of 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD. 10/2/09. Background. Tumor hypoxia is an important prognostic factor in cervical cancer and predicts for decreased overall and disease-free survival

406 views • 12 slides

CONCLUSIONS

a. b. CARATTERIZZAZIONE DI LESIONI DI ORIGINE SCONOSCIUTA SOSPETTE PER LESIONI MALIGNE NEI PAZIENTI PEDIATRICI: POSSIBILE RUOLO DEL 18F-FDG PET/CT A.Cistaro 1 , , E. Basso 2 , R. Laudati 2 , M. Bianchi 2 , M. Piglione 2 , S. Lijoi 2 , A. Linari 3 , P. Fania 1 , E. Panighetto 1 , F. Fagioli 2.

101 views • 1 slides

V. Arena 1 , S. Novello 2 , A. Skanjeti 1 , G. Selvaggi 2 ,

117 views • 1 slides